Skip to main content
Log in

99mTc–Evans Blue Dye for Mapping Contiguous Lymph Node Sequences and Discriminating the Sentinel Lymph Node in an Ovine Model

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to investigate the potential of 99mTc–Evans blue for discriminating the sentinel lymph node in multitiered lymph node sequences by using an ovine model. 99mTc–Evans blue is an agent that has both radioactive and color signals in a single dose. Previous studies in smaller animal models suggested that this agent could have advantages over the dual-injection technique of radiocolloid/blue dye.

Methods

Doses of 99mTc–Evans blue (∼ 21 MBq) containing Evans blue dye (approximately 4 mg) were administered to the hind limbs or fore limbs of sheep to map the lymphatic drainage patterns, validate its ability to identify the sentinel lymph node, and examine the reproducibility of the technique. The study protocol was repeated with 99mTc–antimony trisulfide colloid and Patent Blue V dye. After the operative exposure, lymph nodes were identified with the gamma probe and then excised and analyzed for radioactivity (percentage of injected dose) and blue color.

Results

After the administration of 99mTc–Evans blue, all lymph nodes harvested (35 of 35) in either short chains or long basins were hot and blue. The sentinel lymph nodes concentrated more radioactivity than the second-tier nodes to the extent of 2:1 to 215:1. For radiocolloid/Patent Blue V, the ratios were lower, at 2:1 to 3:1.

Conclusions

99mTc–Evans blue was found to better discriminate the sentinel lymph node than 99mTc–antimony trisulfide colloid/Patent Blue V in variable multitier lymph node anatomy, and it is an agent that promises to have positive clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999; 91:368–73

    CAS  PubMed  Google Scholar 

  2. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130:654–8

    CAS  PubMed  Google Scholar 

  3. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392–9

    CAS  PubMed  Google Scholar 

  4. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001; 192:684–9

    CAS  PubMed  Google Scholar 

  5. Noguchi M. Sentinel lymph node biopsy and breast cancer. Br J Surg 2002; 89:21–34

    CAS  PubMed  Google Scholar 

  6. McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS. The breast cancer patient with multiple sentinel nodes: when to stop? J Am Coll Surg 2001; 192:692–7

    Article  CAS  PubMed  Google Scholar 

  7. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000; 18:2560–6

    CAS  PubMed  Google Scholar 

  8. Martin RC II, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group. Surgery 2000; 128:139–44

    Article  PubMed  Google Scholar 

  9. Kern KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 2002; 195:467–75

    PubMed  Google Scholar 

  10. Cox CE, Haddad F, Bass S, et al. Lymphatic mapping in the treatment of breast cancer. Oncology 1998; 12:1283–92

    CAS  PubMed  Google Scholar 

  11. Nathanson SD, Wachna DL, Gilman D, Karvelis K, Havstad S, Ferrara J. Pathways of lymphatic drainage from the breast. Ann Surg Oncol 2001; 8:821–7

    Google Scholar 

  12. Koizumi M, Nomura E, Yamada Y, et al. Radioguided sentinel node detection in breast cancer patients: comparison of 99mTc phytate and 99mTc rhenium colloid efficacy. Nucl Med Commun 2004; 25:1031–7

    PubMed  Google Scholar 

  13. Tsopelas C, Sutton R. Erratum. Nomenclature of lymphatic staining agents. J Nucl Med 2003; 44:649.

    CAS  Google Scholar 

  14. Motomura K, Inaji H, Komoike Y, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 2001; 76:95–9

    Article  CAS  PubMed  Google Scholar 

  15. Bobin JY, Zinzindohoue C, Isaac S, Saadat M, Roy P. Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. Eur J Cancer 1999; 35:569–73

    Article  CAS  PubMed  Google Scholar 

  16. Bobin JY, Spirito C, Isaac S, et al. Lymph node mapping and axillary sentinel lymph node biopsy in 243 invasive breast cancers with no palpable nodes. The south Lyon hospital center experience (in French). Ann Chir 2000; 125:861–70

    Article  CAS  PubMed  Google Scholar 

  17. Tsopelas C. Technetium-99m labeling of a molecule bearing easily reducible groups. Nucl Med Biol 2000; 27:797–802

    CAS  PubMed  Google Scholar 

  18. Tsopelas C, Penglis S. Visualisation of lymphatic flow in a rabbit model using 99mTc-labelled dyes. Hellenic J Nucl Med 2000; 3:96–101

    Google Scholar 

  19. Sutton R, Tsopelas C, Chatterton B, Coventry B, Kollias J. Sentinel node biopsy and lymphoscintigraphy with a technetium 99m labeled blue dye in a rabbit model. Surgery 2002; 131:44–9

    Article  PubMed  Google Scholar 

  20. Tsopelas C, Sutton R. Why certain dyes are useful for localising the sentinel lymph node. J Nucl Med 2002; 43:1377–82

    CAS  PubMed  Google Scholar 

  21. Tsopelas C. Particle size analyses of 99Tc-labelled and unlabelled rhenium sulfide and antimony trisulphide colloids intended for application in lymphoscintigraphic studies. J Nucl Med 2001; 42:467–75

    Google Scholar 

  22. Uren RF, Thompson JF, Howman-Giles RB. Lymphatic Drainage of the Skin and Breast—Locating Sentinel Nodes. Singapore: Harwood Academic, 1999 :11–3

    Google Scholar 

  23. El-Tamer M, Saouaf R, Wang T, Fawwaz R. A new agent, blue and radioactive, for sentinel node detection. Ann Surg Oncol 2003; 10:323–9

    Article  PubMed  Google Scholar 

  24. Farquhar WB, Hunt BE, Taylor JA, Darling SE, Freeman R. Blood volume and its relation to peak O2 consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol 2002; 282:H66–71

    CAS  PubMed  Google Scholar 

  25. Ross MG, Devoe LD, Rosen KG. ST-segment analysis of the fetal electrocardiogram improves fetal heart rate tracing interpretation and clinical decision making. J Matern Fetal Neonatal Med 2004; 15:181–5

    CAS  PubMed  Google Scholar 

  26. Bernstein IM, Shapiro RE, Whitsel A, Schonberg AL. Relationship of plasma volume to sympathetic tone in nulliparous women. Am J Obstet Gynecol 2003; 188:938–42

    Article  PubMed  Google Scholar 

  27. Brady SL, Hildner CD, Hutchins BF. Simultaneous videofluoroscopic swallow study and modified Evans blue dye procedure: an evaluation of blue dye visualization in cases of known aspiration. Dysphagia 1999; 14:146–9

    Article  CAS  PubMed  Google Scholar 

  28. Amantea SL, Piva JP, Sanches PR, Palombini BC. Oropharyngeal aspiration in pediatric patients with endotracheal intubation. Pediatr Crit Care Med 2004; 5:152–6

    PubMed  Google Scholar 

  29. Zhang S, Wang S, Yao S. Evidence for development of capillary leak syndrome associated with cardiopulmonary bypass in pediatric patients with the homozygous C4A null phenotype. Anesthesiology 2004; 100:1387–93

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Glenda Summersides, Tim Kuchel, BVSc (Hons), MVS, DVA, MRCVS, and the Animal Care Facility staff at the Institute of Medical and Veterinary Sciences for their assistance in preparing sheep before surgery.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chris Tsopelas PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsopelas, C., Bevington, E., Kollias, J. et al. 99mTc–Evans Blue Dye for Mapping Contiguous Lymph Node Sequences and Discriminating the Sentinel Lymph Node in an Ovine Model. Ann Surg Oncol 13, 692–700 (2006). https://doi.org/10.1245/ASO.2006.04.020

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2006.04.020

Keywords

Navigation